Global In Vivo Cro Market Size & Outlook, 2023-2030
Global in vivo cro market, 2018-2030 (US$M)
Related Markets
Global in vivo cro market highlights
- The global in vivo cro market generated a revenue of USD 4,613.0 million in 2023 and is expected to reach USD 7,957.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.1% by 2030.
- In terms of segment, small molecule accounted for a revenue of USD 2,935.0 million in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 4,613.0 million |
| Market revenue in 2030 | USD 7,957.1 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
Other key industry trends
- In terms of revenue, the North America accounted for 50.0% of the global in vivo cro market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Argentina is the fastest growing regional market and is projected to reach USD 43.5 million by 2030.
Small molecule was the largest segment with a revenue share of 63.62% in 2023. Horizon Databook has segmented the Global in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Budget scrutiny in developed countries, pricing pressure, & changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by pharmaceutical and biotech companies.
This trend is expected to boost the drug and medical device outsourcing to emerging countries such as India and China. Stringent processes for FDA approval and regulatory changes in EU region are expected to make approval processes in Europe complex and are some of the major factors responsible for offshoring contract research services to emerging countries.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global in vivo cro market size, by regions, 2018-2030 (US$M)
Top 10 countries: In vivo cro market size, 2023 (US$M)
Global in vivo cro market share, by modality type, 2023 & 2030 (%, US$M)
In vivo cro market: Opportunity assessment by country
Global in vivo cro market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
